SIO GENE THERAPIES INC - COMMON (SIOX)

CUSIP: 829399104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COMMON
Total 13F shares
20,679,712
Share change
+2,579,420
Total reported value
$8,528,467
Put/Call ratio
0%
Price per share
$0.36
Number of holders
29
Value change
+$1,692,078
Number of buys
11
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 829399104?
CUSIP 829399104 identifies SIOX - SIO GENE THERAPIES INC - COMMON in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SIO GENE THERAPIES INC - COMMON (SIOX) as of Q2 2022

As of 30 Jun 2022, SIO GENE THERAPIES INC - COMMON (SIOX) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,679,712 shares. The largest 10 holders included Rubric Capital Management LP, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Hudson Bay Capital Management LP, Newtyn Management, LLC, Cladis Investment Advisory, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Clearline Capital LP, and BlackRock Inc.. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.